HOME >> BIOLOGY >> NEWS
UCR-led research team receives $5 million grant to study interaction of ecology and evolution

RIVERSIDE, Calif. -- An interdisciplinary team of researchers led by David Reznick, an evolutionary biologist at UC Riverside, has been awarded $5 million over five years by the National Science Foundation (NSF) to conduct an experimental study on how ecology a branch of science concerned with the interrelationship of an organism and its environment and evolution interact. The findings of the study are expected to help explain how environmental changes influence an organism's evolution as well as how the evolving organism, in turn, changes the ecosystem in which it is embedded.

Reznick, a professor of biology and the principal investigator of the grant from NSF's Frontiers in Integrative Biological Research (FIBR) program, in collaboration with colleagues specializing in molecular biology, population ecology, ecosystems science, biogeochemistry and applied mathematics, will perform the study of evolution/ecology interactions in natural stream communities on the island of Trinidad.

Specifically, the team will focus on guppies small fresh-water fish biologists have studied for long that coexist in the stream with Hart's killifish, a predator. The team will examine not only what causes the guppies to evolve as they might but also the co-evolution of the killifish.

"We know the fish are evolving, but the ecosystem they find themselves in is also changing," Reznick said. "It is popularly thought that evolution is so much slower than ecology that the two can be thought of as independent, but our results for guppies and those for other organisms show that evolution can be so fast that it happens on time scales that are similar to ecological interactions. If this is true, then changes in the ecosystem, such as the availability of resources or how many predators there are or the cycling of essential nutrients, can exert new evolutionary pressures on the guppies at the
'"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
6-Oct-2006


Page: 1 2 3

Related biology news :

1. UCR-led study identifies crucial mechanism involved in immune response against viruses
2. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
3. Saudi Arabias KAUST names WHOI first research partner
4. Multinational research: protecting ecology means understanding people, too
5. Newly created cancer stem cells could aid breast cancer research
6. Carnegie Mellons Peter Adams receives EPA research grant
7. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
8. Innovative tagging technique may help researchers better protect fish stocks
9. Penn researchers discover how key protein stops inflammation
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. ASU researchers partner with UOP to make biofuel for military jets a reality

Post Your Comments:
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: